Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer. (September 2017)

Record Type:: Journal Article
Title:: Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer. (September 2017)
Main Title:: Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
Authors:: Bilgin, Burak
Şendur, Mehmet AN
Hızal, Mutlu
Akıncı, Muhammed Bülent
Şener Dede, Didem
Yalçın, Bulent
Abstract:
Is Part Of:: Future oncology. Volume 13:Number 22(2017)
Journal:: Future oncology
Issue:: Volume 13:Number 22(2017)
Issue Display:: Volume 13, Issue 22 (2017)
Year:: 2017
Volume:: 13
Issue:: 22
Issue Sort Value:: 2017-0013-0022-0000
Page Start:: 1911
Page End:: 1913
Publication Date:: 2017-09
Subjects:: abiraterone -- androgen deprivation therapy -- docetaxel -- prostate cancer
Oncology -- Periodicals
616.99405
Journal URLs:: http://www.futuremedicine.com/loi/fon ↗
http://www.futuremedicine.com/ ↗
DOI:: 10.2217/fon-2017-0270 ↗
Languages:: English
ISSNs:: 1479-6694
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4060.610420
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 22421.xml